Cubist Systematic Strategies, LLC Crispr Therapeutics Ag Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $1.28 Million - $2.4 Million	33,195 New	33,195 $2.08 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $6.47 Million - $8.85 Million	-157,691 Reduced 93.63%	10,736 $485,000
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $6.22 Million - $10.4 Million	158,738 Added 1638.33%	168,427 $6.85 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $1.88 Million - $2.58 Million	-30,803 Reduced 76.07%	9,689 $633,000
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $408,134 - $697,029	9,441 Added 30.4%	40,492 $2.46 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $67,285 - $100,238	1,265 Added 4.25%	31,051 $1.95 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $1.66 Million - $2.64 Million	23,689 Added 388.54%	29,786 $2.26 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $807,766 - $1.15 Million	-7,330 Reduced 54.59%	6,097 $682,000
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $944,568 - $1.52 Million	9,367 Added 230.71%	13,427 $2.17 Million
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $4.9 Million - $9.3 Million	-44,278 Reduced 91.6%	4,060 $495,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $581,670 - $1.26 Million	7,301 Added 17.79%	48,338 $7.4 Million
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $2.26 Million - $2.9 Million	28,777 Added 234.72%	41,037 $3.43 Million
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $50,435 - $99,625	-1,310 Reduced 9.65%	12,260 $901,000
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $1.13 Million - $2.1 Million	-33,570 Reduced 71.21%	13,570 $576,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $1.51 Million - $3 Million	41,040 Added 672.79%	47,140 $2.87 Million
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $43,039 - $55,188	-1,050 Reduced 14.69%	6,100 $250,000
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $168,990 - $229,769	4,767 Added 200.04%	7,150 $337,000
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $1.04 Million - $1.52 Million	-37,167 Reduced 93.97%	2,383 $85,000
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $783,389 - $1.46 Million	34,465 Added 677.78%	39,550 $1.13 Million
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $225,519 - $334,135	5,085 New	5,085 $226,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$367 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$347 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$139 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$137 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$137 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account